|
The new Genesis 355-150 S from Coherent,
Inc. (Santa Clara, CA) (Nasdaq: COHR) sets a new power record for true CW
ultraviolet solid-state performance, delivering over 150 milliwatts of TEM00
output for flow cytometry and other live-cell bio applications. This new laser,
as with all other Genesis 355 series lasers, is based on the company’s
patented optically pumped semiconductor laser (OPSL) technology, which has become
the technology of choice in many biomedical applications for visible wavelengths.
This new laser is a true CW source of 355 nm UV laser light avoiding the potential
high peak power problems arising from older quasi CW lasers. With low output
noise and a single spatial output mode (M2 <1.2), the new Genesis 355-150
S laser is ideal for high-throughput applications needing best signal-to-noise
ratio data.
The high power of the Genesis 355-150 S is intended to increase the throughput
of live cell applications including flow cytometry, such as egg and fertilized-egg
sorting, where the peak power of alternative, modelocked lasers poses significant
risk of mutagenic damage to the DNA in the sorted cells. It is also an excellent
source for other fluorescence-based applications, including confocal microscopy,
where its short wavelength and low M2 beam provide optimum excitation of Hoechst
and Indo dyes. Moreover, these confocal microscopes often rely on fiber delivery
which can be problematic for the high peak power levels of quasi CW lasers.
Founded in 1966, Coherent, Inc. is a Russell 2000 Index company and a world
leader in providing laser-based solutions to the commercial and scientific research
markets. Please direct any questions to Arnaud Lepert, product line manager,
at (408) 764-4657, e-mail arnaud.lepert@coherent.com.
For more information about Coherent, including product and financial updates,
visit our website at http://www.Coherent.com.
Published Date: 16/8/2009
Click here for optics news archive
|
